BIOMAT Database Logo BIOMAT Database Logo

Three-dimensional structure-activity relationships. 1988

G R Marshall, and R D Cramer

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

G R Marshall, and R D Cramer
[Three dimensional structure-activity relationships].
January 1998, Acta pharmaceutica Hungarica,
G R Marshall, and R D Cramer
Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors.
June 1996, Journal of computer-aided molecular design,
G R Marshall, and R D Cramer
Three-dimensional quantitative structure-activity relationships of sulfonamide endothelin inhibitors.
February 1995, Journal of medicinal chemistry,
G R Marshall, and R D Cramer
Three-dimensional quantitative structure--activity relationships for androgen receptor ligands.
April 1996, Toxicology and applied pharmacology,
G R Marshall, and R D Cramer
Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitors.
May 2004, Journal of computer-aided molecular design,
G R Marshall, and R D Cramer
Three-dimensional quantitative structure-activity relationships (3D-QSAR) of antidiabetic thiazolidinediones.
August 1999, Drug design and discovery,
G R Marshall, and R D Cramer
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
May 2002, Molecular pharmacology,
G R Marshall, and R D Cramer
Exploring Structure-Activity Relationships with Three-Dimensional Matched Molecular Pairs-A Review.
March 2018, ChemMedChem,
G R Marshall, and R D Cramer
Three-dimensional quantitative structure activity relationships (3-D-QSAR) of antihyperglycemic agents.
July 1999, Bioorganic & medicinal chemistry,
G R Marshall, and R D Cramer
Three-dimensional quantitative structure-activity relationships of mazindol analogues at the dopamine transporter.
September 2002, Journal of medicinal chemistry,
Copied contents to your clipboard!